Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion

Journal of Immunological Methods

Volumn 293, Issue 1-2, 2004, Pages 1-11

  Diaz Padilla, Niubel ^a   Ciurana, Caroline ^a   Van Oers, Joep ^a   Ogilvie, Aernout C ^a   Hack, C Erik ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; ELISA; Inflammation; Natural antibodies

Indexed keywords

4 AMINOPHENYLPHOSPHORYLCHOLINE; ANTIGEN; CHOLINE DERIVATIVE; GLYCINE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; PHOSPHOSERINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CIRCULATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH STATUS; HUMAN; LIMB PERFUSION; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SERUM; TUMOR;

ANIMALS; APOPTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTREMITIES; HUMANS; IMMUNOGLOBULIN M; MICE; PERFUSION; PHOSPHORYLCHOLINE;

EID: 7944230095     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.06.011     Document Type: Article

References (33)

1. C.J. Binder, S. Horkko, A. Dewan, M.K. Chang, E.P. Kieu, C.S. Goodyear, P.X. Shaw, W. Palinski, J.L. Witztum, and G.J. Silverman Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL Nat. Med. 9 2003 736
2. R.L. Brey, S.A. Cote, D.L. McGlasson, D.A. Triplett, and L.K. Barna Effects of repeated freeze-thaw cycles on anticardiolipin antibody immunoreactivity Am. J. Clin. Pathol. 102 1994 586
3. D.E. Briles, M. Nahm, K. Schroer, J. Davie, P. Baker, J. Kearney, and R. Barletta Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae J. Exp. Med. 153 1981 694
4. M.K. Chang, C. Bergmark, A. Laurila, S. Horkko, K.H. Han, P. Friedman, E.A. Dennis, and J.L. Witztum Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition Proc. Natl. Acad. Sci. U. S. A. 96 1999 6353
5. M.K. Chang, C.J. Binder, M. Torzewski, and J.L. Witztum C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids Proc. Natl. Acad. Sci. U. S. A. 99 2002 13043
6. Ciurana, C.L.F., Hack, C.E. Competitive binding of pentraxins and IgM to newly exposed epitopes on late apoptotic cells, in press.
7. A. Freijd, A. Jonsson, and B. Rynnel-Dagoo Age-dependent IgG subclass distribution of phosphocholine antibodies in humans APMIS, Acta Pathol., Microbiol. Immunol. Scand. 96 1988 901
8. P. Friedman, S. Horkko, D. Steinberg, J.L. Witztum, and E.A. Dennis Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration J. Biol. Chem. 277 2002 7010
9. P.J. Gearhart, N.H. Sigal, and N.R. Klinman Heterogeneity of the BALB/c antiphosphorylcholine antibody response at the precursor cell level J. Exp. Med. 141 1975 56
10. Gershov, D., Kim, S., Brot, N., Elkon, K.B., 2000. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. (Nov. 6.) 192(9) 1353-1364, 192, 1353.
11. S. Horkko, D.A. Bird, E. Miller, H. Itabe, N. Leitinger, G. Subbanagounder, J.A. Berliner, P. Friedman, E.A. Dennis, L.K. Curtiss, W. Palinski, and J.L. Witztum Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins J. Clin. Invest. 103 1999 117
12. A.B. Kantor, C.E. Merrill, L.A. Herzenberg, and J.L. Hillson An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells J. Immunol. 158 1997 1175
13. J.F. Kearney Immune recognition of OxLDL in atherosclerosis J. Clin. Invest. 105 2000 1683
14. S.J. Kim, D. Gershov, X. Ma, N. Brot, and K.B. Elkon I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation J. Exp. Med. 196 2002 655
15. K. Koizumi, V. Poulaki, S. Doehmen, G. Welsandt, S. Radetzky, A. Lappas, N. Kociok, B. Kirchhof, and A.M. Joussen Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo Invest. Ophthalmol. Vis. Sci. 44 2003 2184
16. S. Kono, H. Kuzuya, K. Yamada, Y. Yoshimasa, M. Okamoto, H. Nishimura, A. Kosaki, G. Inoue, T. Hayashi, and H. Imura Preparation of anti-phosphoserine and anti-phosphothreonine antibodies and their application in the study of insulin- and EGF-induced phosphorylation Biochem. Biophys. Res. Commun. 190 1993 283
17. C. Mold, B. Rodic-Polic, and T.W. Du Clos Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors J. Immunol. 168 2002 6375
18. J. Nilsson, F. Calara, J. Regnstrom, A. Hultgardh-Nilsson, S. Ameli, B. Cercek, and P.K. Shah Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits J. Am. Coll. Cardiol. 30 1997 1886
19. W. Palinski, E. Miller, and J.L. Witztum Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis Proc. Natl. Acad. Sci. U. S. A. 92 1995 821
20. W. Palinski, S. Horkko, E. Miller, U.P. Steinbrecher, H.C. Powell, L.K. Curtiss, and J.L. Witztum Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma J. Clin. Invest. 98 1996 800
21. M.B. Pepys, and G.M. Hirschfield C-reactive protein: a critical update J. Clin. Invest. 111 2003 1805
22. N. Rose, and M. Afanasyeva Autoimmunity: busting the atherosclerotic plaque Nat. Med. 9 2003 641
23. P.X. Shaw, S. Horkko, M.K. Chang, L.K. Curtiss, W. Palinski, G.J. Silverman, and J.L. Witztum Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity J. Clin. Invest. 105 2000 1731
24. P.X. Shaw, C.S. Goodyear, M.K. Chang, J.L. Witztum, and G.J. Silverman The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis- associated neo-antigens and apoptotic cells J. Immunol. 170 2003 6151
25. N.H. Sigal, P.J. Gearhart, and N.R. Klinman The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB/C mice J. Immunol. 114 1975 1354
26. D. Thompson, M.B. Pepys, and S.P. Wood The physiological structure of human C-reactive protein and its complex with phosphocholine structure Fold. Des. 7 1999 169
27. W.S. Tillet, and T. Francis Serological reactions in pneumonia with a non protein somatic fraction of pneumococcus J. Exp. Med. 52 1930 561
28. R.J. van Ginkel, H.J. Hoekstra, A.M. Eggermont, E. Pras, and H.S. Koops Isolated limb perfusion of an irradiated foot with tumor necrosis factor, interferon, and melphalan Arch. Surg. 131 1996 672
29. J.E. Volanakis, and M.H. Kaplan Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide Proc. Soc. Exp. Biol. Med. 136 1971 612
30. B.C. Vrouenraets, B.B. Kroon, A.C. Ogilvie, A.N. van Geel, O.E. Nieweg, A.J. Swaak, and A.M. Eggermont Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan Ann. Surg. Oncol. 6 1999 405
31. G.J. Wolbink, M.C. Brouwer, S. Buysmann, I.J. ten Berge, and C.E. Hack CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes J. Immunol. 157 1996 473
32. R. Wu, Y.H. Huang, L.S. Elinder, and J. Frostegard Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL Arterioscler. Thromb. Vasc. Biol. 18 1998 626
33. B. Zwart, C. Ciurana, I. Rensink, R. Manoe, C.E. Hack, and L.A. Aarden Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells Autoimmunity 37 2 2004 95